Salvage Ex Situ Hepatectomy With Liver Autotransplantation for Recurrent Intraductal Papillary Neoplasm of the Bile Ducts (IPNB): A Case Report.

Transplant ProcJul 23, 2026 (epub)

Gabriel Bayona-Alvarado, Daniel Reis Waisberg, Rafael Soares Pinheiro et al.

✦ AI-curated · Sources linked

Case in brief

A 64-year-old woman with a history of left hepatectomy for intraductal papillary neoplasm of the bile ducts developed recurrent disease in the caudate lobe, closely associated with major vascular structures. She underwent salvage ex situ hepatectomy with liver autotransplantation, which involved meticulous dissection and vascular reconstruction. The procedure was successful, with negative margins on histopathology, and the patient was discharged on postoperative day 15.

Diagnostic / clinical pearl

Ex situ hepatectomy with liver autotransplantation can be a viable option for patients with recurrent hepatic tumors in complex anatomical locations, allowing for radical resections.

Why it matters

This case highlights the potential of advanced surgical techniques in managing challenging hepatic tumors, expanding treatment options for patients with limited alternatives.

Source

Published in Transplant Proc. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.